2022 Revenues ($USD) : $958,102,000
2022 R&D spend : $97,346,000
2022 Number of Employees : 2,400
Fiscal Year End : 12/31/2021
Company CEO : Daniel Scavilla, CEO and president

Globus Medical appears to have delivered a needed rebound during its second quarter after a Q1 earnings miss and a surprise CEO transition. The company reached another milestone in its business earlier this year with the first shipments of its Excelsius3D imaging system. Globus Medical announced the first procedures using the system in May. The mobile X-ray system is designed for 2D fluoroscopy, 2D digital radiography and 3D imaging of adult and pediatric patients. When combined with its ExcelsiusGPS, the image-guided robotic navigation improves implant placement accuracy. –CN